| Dr Nishant Michael De Quadros, MD | |
|
710 Center St, The Medical Center, Columbus, GA 31901-2608 | |
| (706) 501-1000 | |
| Not Available |
| Full Name | Dr Nishant Michael De Quadros |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 18 Years |
| Location | 710 Center St, Columbus, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003027285 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 4301087927 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Columbus Regional Midtown | Columbus, GA | Hospital |
| Piedmont Columbus Regional Northside | Columbus, GA | Hospital |
| Clinch Memorial Hospital | Homerville, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Columbus Diagnostic Center Inc | 3375455884 | 36 |
| Northside Radiology Associates Llc | 4486555398 | 213 |
News Archive
A research team at Emory University is embarking on a multipronged study of 3q29 deletion syndrome, a genetic mutation associated with a 40-fold increased risk for schizophrenia and a range of other neuropsychiatric conditions including mild to moderate intellectual disability, autism and anxiety.
A new study reports that BNT162b2 booster doses are safe and have shown enhancement in short-term protection against the Delta variant.
Ipsen, a global biotechnology specialty care group, and Rhythm Pharmaceuticals, a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that they have concluded a license agreement for Ipsen's proprietary peptide therapeutics targeting obesity, metabolic diseases, and gastrointestinal disorders.
People may be learning while they're sleeping - an unconscious form of memory that is still not well understood, according to a study by Michigan State University researchers.
› Verified 8 days ago
| Entity Name | Northside Radiology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013960657 PECOS PAC ID: 4486555398 Enrollment ID: O20040115000095 |
News Archive
A research team at Emory University is embarking on a multipronged study of 3q29 deletion syndrome, a genetic mutation associated with a 40-fold increased risk for schizophrenia and a range of other neuropsychiatric conditions including mild to moderate intellectual disability, autism and anxiety.
A new study reports that BNT162b2 booster doses are safe and have shown enhancement in short-term protection against the Delta variant.
Ipsen, a global biotechnology specialty care group, and Rhythm Pharmaceuticals, a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that they have concluded a license agreement for Ipsen's proprietary peptide therapeutics targeting obesity, metabolic diseases, and gastrointestinal disorders.
People may be learning while they're sleeping - an unconscious form of memory that is still not well understood, according to a study by Michigan State University researchers.
› Verified 8 days ago
| Entity Name | Columbus Diagnostic Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316108624 PECOS PAC ID: 3375455884 Enrollment ID: O20040429001218 |
News Archive
A research team at Emory University is embarking on a multipronged study of 3q29 deletion syndrome, a genetic mutation associated with a 40-fold increased risk for schizophrenia and a range of other neuropsychiatric conditions including mild to moderate intellectual disability, autism and anxiety.
A new study reports that BNT162b2 booster doses are safe and have shown enhancement in short-term protection against the Delta variant.
Ipsen, a global biotechnology specialty care group, and Rhythm Pharmaceuticals, a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that they have concluded a license agreement for Ipsen's proprietary peptide therapeutics targeting obesity, metabolic diseases, and gastrointestinal disorders.
People may be learning while they're sleeping - an unconscious form of memory that is still not well understood, according to a study by Michigan State University researchers.
› Verified 8 days ago
| Entity Name | Georgia Radiology Imaging Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831461771 PECOS PAC ID: 5698930774 Enrollment ID: O20120625000184 |
News Archive
A research team at Emory University is embarking on a multipronged study of 3q29 deletion syndrome, a genetic mutation associated with a 40-fold increased risk for schizophrenia and a range of other neuropsychiatric conditions including mild to moderate intellectual disability, autism and anxiety.
A new study reports that BNT162b2 booster doses are safe and have shown enhancement in short-term protection against the Delta variant.
Ipsen, a global biotechnology specialty care group, and Rhythm Pharmaceuticals, a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that they have concluded a license agreement for Ipsen's proprietary peptide therapeutics targeting obesity, metabolic diseases, and gastrointestinal disorders.
People may be learning while they're sleeping - an unconscious form of memory that is still not well understood, according to a study by Michigan State University researchers.
› Verified 8 days ago
| Entity Name | Louisville Radiology Imaging Consultants Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639115447 PECOS PAC ID: 2264436120 Enrollment ID: O20130321000039 |
News Archive
A research team at Emory University is embarking on a multipronged study of 3q29 deletion syndrome, a genetic mutation associated with a 40-fold increased risk for schizophrenia and a range of other neuropsychiatric conditions including mild to moderate intellectual disability, autism and anxiety.
A new study reports that BNT162b2 booster doses are safe and have shown enhancement in short-term protection against the Delta variant.
Ipsen, a global biotechnology specialty care group, and Rhythm Pharmaceuticals, a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that they have concluded a license agreement for Ipsen's proprietary peptide therapeutics targeting obesity, metabolic diseases, and gastrointestinal disorders.
People may be learning while they're sleeping - an unconscious form of memory that is still not well understood, according to a study by Michigan State University researchers.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nishant Michael De Quadros, MD 1701 Williams Ct, Apt 1103, Columbus, GA 31904-3901 Ph: (216) 374-9444 | Dr Nishant Michael De Quadros, MD 710 Center St, The Medical Center, Columbus, GA 31901-2608 Ph: (706) 501-1000 |
News Archive
A research team at Emory University is embarking on a multipronged study of 3q29 deletion syndrome, a genetic mutation associated with a 40-fold increased risk for schizophrenia and a range of other neuropsychiatric conditions including mild to moderate intellectual disability, autism and anxiety.
A new study reports that BNT162b2 booster doses are safe and have shown enhancement in short-term protection against the Delta variant.
Ipsen, a global biotechnology specialty care group, and Rhythm Pharmaceuticals, a biotechnology company developing peptide therapeutics for metabolic diseases, announced today that they have concluded a license agreement for Ipsen's proprietary peptide therapeutics targeting obesity, metabolic diseases, and gastrointestinal disorders.
People may be learning while they're sleeping - an unconscious form of memory that is still not well understood, according to a study by Michigan State University researchers.
› Verified 8 days ago
Christopher Leon Mcintire, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 616 19th St, Doctors Hospital, Columbus, GA 31901 Phone: 706-494-4282 Fax: 706-494-4459 | |
Dr. George M Benashvili, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 710 Center St, Department Of Radiology, Columbus, GA 31901 Phone: 706-571-1064 Fax: 706-571-1986 | |
Douglas W Wallace, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2300 Manchester Expy, Ste A001, Columbus, GA 31904 Phone: 706-257-7700 Fax: 706-257-7708 | |
Dr. Gilbert Orson Maulsby, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 7629 River Crest Dr, Columbus, GA 31904 Phone: 706-641-8272 | |
Robert L Garnett, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2122 Manchester Expy, St Francis Hospital, Columbus, GA 31904 Phone: 706-596-4115 Fax: 706-596-4119 | |
Dr. Glen Andrew Vahjen, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 710 Center St, Department Of Radiology, Columbus, GA 31901 Phone: 706-571-1064 Fax: 706-571-1986 |